Lexaria Receives Four New Granted Patents
Portfolio Pulse from Benzinga Newsdesk
Lexaria Bioscience Corp. has been granted four new patents, further strengthening its intellectual property portfolio. The patents cover various aspects of the company's DehydraTECH technology, which enhances the delivery of active pharmaceutical ingredients.

June 20, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lexaria Bioscience Corp. has been granted four new patents, which could potentially increase the value of its DehydraTECH technology and strengthen its market position.
The four new patents granted to Lexaria Bioscience Corp. directly relate to its DehydraTECH technology, which is a key aspect of the company's product offerings. This strengthens its intellectual property portfolio and could potentially increase the value of the technology, leading to a positive short-term impact on the company's stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100